Towa Pharmaceutical has filed a patent for a novel agent or composition containing caryophyllene. The agent is used for promoting relaxation, sleep, and preventing blood pressure elevation. The patent also includes a method for inhaling ß-caryophyllene while smoking a tobacco product, which allows for efficient distribution throughout the body, leading to relaxing and sleep-inducing effects. GlobalData’s report on Towa Pharmaceutical gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Towa Pharmaceutical, nanoparticle drug conjugates was a key innovation area identified from patents. Towa Pharmaceutical's grant share as of June 2023 was 1%. Grant share is based on the ratio of number of grants to total number of patents.
The patent is filed for a composition promoting relaxation and sleep
A recently filed patent (Publication Number: US20230200435A1) describes a composition and method involving caryophyllene, a natural compound found in various plants. The patent claims a composition comprising caryophyllene and a flavoring agent, with the caryophyllene making up at least 1% of the total composition. Additionally, the patent claims a capsule containing caryophyllene, with the core of the capsule containing at least 1% caryophyllene. The caryophyllene can be extracted or concentrated from various plants, including clove, basil, cannabis, and lavender, or it can be chemically synthesized.
The patent also covers the use of caryophyllene in perfumery, cosmetics, food, and drink products. Specifically, it mentions air fresheners, oral care products, and cosmetic products as potential applications. The patent further describes the use of caryophyllene in food or drink products in the form of a capsule.
In addition to its use in various products, the patent claims that caryophyllene can be used to promote relaxation, sleep, and prevent blood pressure elevation. The method involves administering caryophyllene to a subject in need, with various administration methods mentioned, including oral, pulmonary, and dermal administration. Pulmonary administration, particularly using a capsule or filter containing caryophyllene, is highlighted as a specific method. The patent also mentions the use of tobacco products, inhalation devices, perfumery products, and cosmetic products as potential means of administering caryophyllene.
Overall, this patent describes the composition, capsule, and method involving caryophyllene. It highlights the potential applications of caryophyllene in various products, as well as its potential benefits in promoting relaxation, sleep, and preventing blood pressure elevation. The patent provides specific details on the composition and administration methods, including the use of capsules and various products containing caryophyllene.
To know more about GlobalData’s detailed insights on Towa Pharmaceutical, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
